On September 26, 2026, the domain mirna.org was sold via the Afternic platform for $25,000. As a domain representing a specialized term in the life sciences, this transaction underscores the market’s continued recognition of high-quality domain names within vertical industries.
Domain Significance: “miRNA” is the standard abbreviation for microRNA, a core technical term in biomedicine widely used in gene regulation, disease diagnosis, and biopharmaceutical R&D. By utilizing this industry-standard abbreviation as its core, mirna.org is concise, memorable, and inherently linked to scientific research; it is ideally suited for hosting miRNA-related academic platforms, research databases, or educational websites on biomedicine. The .org extension—traditionally favored by non-profits and research institutions—aligns naturally with the positioning of genetic and biological academic projects, making it a better fit for academic communities and public-interest research sites than .com.
In terms of value, “mirna” is an established technical term; it is irreplaceable, enjoys a stable search volume within the industry, and presents no cognitive barrier associated with invented or creative names. Amid the ongoing growth of the biopharmaceutical sector, single-word domains in such niche segments possess significant industry-specific value.
The sale price of $25,000 reflects current market trends for professional domains in vertical technology and biological research. These domains attract a highly targeted audience—typically relevant companies, research teams, or industry entrepreneurs—offering dual value for both investment/collection and practical website development.
As the biotechnology industry continues to evolve, industry-specific domains like mirna.org—which carry authoritative terminology and attract relevant professional traffic—retain strong potential for future marketability.
The article comes from the Internet. If there is any infringement, please notify me to delete it. Please indicate the source when reprinting！
If you have news to publish, please send it to:article@domain.news
